View Older Stories View More Recent Stories

Nov 4, 2025 07:30AM Bioventus Reports Third Quarter Financial Results
Nov 4, 2025 07:11AM Bitcoin Bancorp Partners with Sailo Technologies to Launch Revolutionary Bitcoin Treasury Management Platform Amid Surge in Corporate Adoption
Nov 4, 2025 07:03AM QOL Medical to acquire Evoke Pharma for $11 per share in cash
Nov 4, 2025 07:02AM GENPREX receives European patent intent for cancer gene therapy combination
Nov 4, 2025 07:00AM Magnet Biomedicine Appoints Bharat Reddy, Ph.D., as Chief Business Officer
Nov 4, 2025 07:00AM Zoetis Announces Third Quarter 2025 Results
Nov 4, 2025 07:00AM Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
Nov 4, 2025 07:00AM Compass, Inc. Reports Record Third Quarter 2025 Results
Nov 4, 2025 07:00AM Nature Communications Study Supports HER2DX as a Genomic Tool for Tailored Therapy in Older Individuals With HER2+ Breast Cancer
Nov 4, 2025 07:00AM Genprex Announces European Patent Office's Intent to Grant a Patent for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
Nov 4, 2025 06:58AM GreyNoise Integrates with CrowdStrike Falcon Next-Gen SIEM to Unify Network Intelligence and Accelerate SOC Transformation
Nov 4, 2025 06:55AM Hagerty Reports Third Quarter 2025 Results; Increases 2025 Outlook
Nov 4, 2025 06:50AM Merck receives $700 million from Blackstone for cancer drug development
Nov 4, 2025 06:50AM Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)
Nov 4, 2025 06:50AM BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease
Nov 4, 2025 06:45AM Merck assumes full rights to MK-8690 drug after $150 million Falk deal
Nov 4, 2025 06:45AM Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
Nov 4, 2025 06:45AM Descartes’ Study Finds 67% of Freight Forwarders and Customs Brokers View Technology as Fundamental to Growth
Nov 4, 2025 06:30AM Denison Mines faces judicial review over Wheeler River uranium project
Nov 4, 2025 06:30AM Denison Acknowledges Application for Judicial Review Regarding Provincial Environmental Assessment Approval for Wheeler River
Nov 4, 2025 06:00AM 22nd Century Group Reports Third Quarter 2025 Financial Results
Nov 4, 2025 04:30AM BROAD ARROW’S INAUGURAL ZÜRICH AUCTION ACHIEVES OVER CHF 22M WITH 87 PERCENT SELL-THROUGH RATE
Nov 4, 2025 04:30AM Breakthrough in 5G FWA to Bring High-Speed Broadband to MDUs
Nov 4, 2025 04:00AM SnapLogic Accelerates Enterprise AI Adoption with New Capabilities for Agents, MCP, and Enhanced AI Governance
Nov 4, 2025 04:00AM SnapLogic Eliminates Legacy Migration Costs by up to 80% with SnapLogic Intelligent Modernizer
Nov 4, 2025 03:24AM Bitget Launches Institutional Financing Program Offering Interest-Free 2M USDT to Boost Altcoin Liquidity
Nov 4, 2025 03:05AM Golden Cariboo Resources Commences Autumn Drill Campaign at the Quesnelle Gold Quartz Mine Property
Nov 4, 2025 03:01AM Star Copper Kicks Off Inaugural Drilling at Star North Target
Nov 4, 2025 02:59AM DMG Blockchain Solutions Announces Asset Purchase to Establish its First US-based Data Center, October Preliminary Operational Results
Nov 4, 2025 01:15AM New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline
Nov 3, 2025 10:50PM Best Meme Coins to Buy Today: MoonBull Presale Taps $550K, SHIB Gains FTSE Grayscale Recognition, DOGE Price Pulls Back
Nov 3, 2025 06:27PM New York seeks dismissal of lawsuit by Elon Musk's X over hate speech law
Nov 3, 2025 04:35PM Christopher J.L. Murray Receives 2025 James and Sarah Fries Prize for Improving Health
Nov 3, 2025 04:31PM HII appoints Tim Taylor as VP of engineering at Newport News Shipbuilding
Nov 3, 2025 04:30PM DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
Nov 3, 2025 04:30PM HII Names Tim Taylor as Vice President of Engineering, Technology, and Design at Newport News Shipbuilding
Nov 3, 2025 04:30PM BlackSky to Participate at Three Upcoming Investor Conferences
Nov 3, 2025 04:25PM Best Crypto Coins to Invest In: Bitcoin Price Dips 3.2%, BNB Approaches $1,200 Breakout, MoonBull Presale Surpasses $550K
Nov 3, 2025 04:15PM Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
Nov 3, 2025 04:15PM NANOBIOTIX to Participate in Investor Conferences the Week of November 10th
Nov 3, 2025 04:15PM Hagerty Announces New Partnership with Liberty Mutual
Nov 3, 2025 04:14PM Upwork Reports Third Quarter 2025 Financial Results
Nov 3, 2025 04:05PM Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
Nov 3, 2025 04:04PM NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing
Nov 3, 2025 04:01PM Veradigm appoints Tehsin Syed as chief product and technology officer
Nov 3, 2025 04:01PM Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer
Nov 3, 2025 04:01PM Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
Nov 3, 2025 04:01PM HALOZYME RAISES 2025 FINANCIAL GUIDANCE AND REPORTS STRONG THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS
Nov 3, 2025 04:00PM UCB gains FDA approval for first TK2 deficiency treatment KYGEVVI
Nov 3, 2025 04:00PM U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
View More Recent Stories View Older Stories